<DOC>
	<DOCNO>NCT01962961</DOCNO>
	<brief_summary>The goal study determine n-acetylcysteine , give PharmaNAC , reduce oxidative stress improve vascular function HIV-infected older adult already HIV treatment .</brief_summary>
	<brief_title>N-acetylcysteine Reduce Oxidative Stress Improve Endothelial Function HIV-infected Older Adults</brief_title>
	<detailed_description>The primary objective study compare 8-week change circulate level malondialdehyde ( MDA ) , circulate level F2-isoprostanes , flow-mediated dilation ( FMD ) brachial artery old HIV-infected adult already receive virologically suppressive antiretroviral therapy ( ART ) randomize either NAC 900 mg twice daily , NAC 1800 mg twice daily , placebo . The relative efficacy safety two dos NAC assess .</detailed_description>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>HIV1 infection , document ( 1 ) license rapid HIV test HIV enzyme chemiluminescence immunoassay ( E/CIA ) test kit time prior study entry confirm licensed Western blot second antibody test method initial rapid HIV and/or E/CIA , ( 2 ) two detectable HIV1 antigen , ( 3 ) two detectable plasma HIV1 RNA viral load . Age equal great 50 year . Receipt antiretroviral therapy kind least 6 month prior screen . HIV1 RNA level &lt; 75 copies/mL screening . For woman still reproductive potential , negative urine pregnancy test screen willingness use two form birth control course study . Acceptable form birth control include condom ( without gel kill sperm ) , diaphragm cervical cap ( without gel kill sperm ) , intrauterine device ( IUD ) , hormonalbased birth control ( `` pill '' ) . Inability complete write , informed consent . Incarceration time study visit . Known allergy intolerance nacetylcysteine . Use nacetylcysteine within 180 day screen . Diagnosed vascular disease ( history angina pectoris , coronary disease , peripheral vascular disease , cerebrovascular disease , aortic aneurysm , otherwise know atherosclerotic disease ) . History congestive heart failure even currently compensate . History portal hypertension hepatic cirrhosis ( either clinically diagnose histologically diagnose ) . Diagnosed disease process , besides HIV infection , associate increase systemic inflammation ( include , limited , systemic lupus erythematosis , inflammatory bowel disease , collagen vascular disease ) . Known suspected malignancy require systemic treatment within six month screen . History ADAdefined diabetes mellitus ( 115 ) History migraine headache . History Raynaud 's phenomenon . History cardiac arrhythmia cardiomyopathy . Uncontrolled hyperthyroidism hypothyroidism , define TSH value outside local reference range recent clinical assessment . Asthma COPD require daily use beta2agonist therapy ( e.g . albuterol ) History carotid bruits . Creatinine clearance &lt; 50 mL/min ( use CockcroftGault equation ) use serum creatinine level measure screen . Hemoglobin &lt; 9.0 g/dL screening . Alanine aminotransferase ( ALT ) level aspartate aminotransferase ( AST ) &gt; 3 time ULN screening . Total bilirubin &gt; 2.5 time ULN screening ; participant receiving atazanavir , s/he would exclude total bilirubin &gt; 3.5 time ULN screening . Therapy serious medical illness within 14 day prior screen . Pregnancy breastfeed course study . Uncontrolled hypertension , define systolic blood pressure &gt; 160 mmHg diastolic blood pressure &gt; 100 mmHg screening . Receipt investigational agent , cytotoxic chemotherapy , systemic glucocorticoid ( dose ) , anabolic steroid screen . Previous receipt stavudine didanosine 7 cumulative day . Receipt daily Vitamin C Vitamin E supplement screen . Alcohol intake equivalent one 8 oz . wine daily 7 day prior screen . Active drug use dependence , opinion investigator , would interfere adherence study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>N-acetylcysteine</keyword>
</DOC>